The IQ Working Group has defined a pragmatic risk-based approach to audit trail review, where it is only required for high impact GxP data.
Katria Harasewych
Advertisement
Katria Harasewych works in quality at Merck & Co., Inc. (Kenilworth, NJ).
Articles by Katria Harasewych
A data-integrity risk assessment tool has been developed for use with standalone R&D data-acquisition and processing software.
Advertisement
Latest Updated Articles
Assessing Data Integrity Risks in an R&D EnvironmentPublished: October 1st 2020 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
2
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
5
